Lumos Diagnostics Holdings Limited (ASX: LDX)
Health Care · Health Care Equipment & Supplies · US
AU$0.11
-4.55% today · +9.4% 1Y
Lumos Diagnostics Holdings Limited (ASX: LDX) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $71.08M and employs 29 people.
Over the last twelve months the share price has gained 9.4%, trading between 0.08 and 0.33.
Tweenvest scores Lumos Diagnostics Holdings Limited across four factors: quality 27/100, value 61/100, growth 57/100. Its strongest factor is value.
LDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $71.08M
- Revenue (TTM)
- $12.21M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- AU$0.33
- 52-week low
- AU$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 944.39M
- Employees
- 29
- Next earnings
- —
About Lumos Diagnostics Holdings Limited
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
- ISIN
- AU0000157091
- Founded
- 2018
- Listed since
- Jul 5, 2021
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.